GSK3B and Alzheimer disease: The second insulin receptor signaling pathway, the Akt pathway—which is responsible for cell growth and survival, protein synthesis, and inhibition of the glycogen synthase kinase-3β (GSK-3β) enzyme [71,72,73,74,75]—is also affected by both AD and type 2 diabetes [76].